File(s) under permanent embargo
Alternative targeted therapy for early HER2 positive breast cancer
journal contribution
posted on 2013-02-01, 00:00 authored by S Harvey, Mustafa KhasrawHer2 (erbB2) receptor is overexpressed in around twenty percent of early breast cancer and historically conferred a poorer prognosis (1). Targeted anti-Her2 therapy has significantly improved outcomes for these women.
History
Journal
Gland surgeryVolume
2Issue
1Pagination
42 - 45Publisher
Gland SurgeryLocation
[unknown]Publisher DOI
ISSN
2227-684XeISSN
2227-8575Language
engPublication classification
C1 Refereed article in a scholarly journal; C Journal articleUsage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC